Immune reaction in healthy organs (IMAGE) Innovation Center of NanoMedicine Caption Glucose-PEGylated avelumab increased neither the number of immune cells nor the secretion of proinflammatory cytokines in the lung, kidney, and liver. Immune related adverse event (irAE) can be prevented. Credit 2021 Innovation Center of NanoMedicine Usage Restrictions All rights reserved License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.